The essential role of CCT2 in the regulation of aggrephagy
Jie Luo1, Ze-Sen Feng1, Ji-Xin Tang1
1Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Diseases of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Abstract:
Protein aggregation, a defining characteristic of numerous human diseases, poses a significant challenge to cellular health. Autophagy, an essential cellular recycling process, specifically targets and degrades these harmful protein aggregates through a specialized mechanism known as aggrephagy. However, the precise mechanisms underlying the exquisite selectivity of aggrephagy in identifying and eliminating only aggregated proteins while sparing healthy cellular components have remained enigmatic. Here, in this mini review, we highlights the essential role of CCT2, a subunit of the chaperonin TRiC complex, in regulating aggrephagy. CCT2, traditionally viewed as a molecular chaperone, has emerged as a novel autophagy receptor that specifically targets solid protein aggregates for degradation. This ubiquitination-independent mode of recognition by CCT2 expands our understanding of protein degradation pathways. The functional switch of CCT2 from a chaperone to an autophagy receptor underscores its dynamic nature and ability to adapt to cellular stress. The selectivity of CCT2-mediated aggrephagy for solid aggregates has implications for neurodegenerative diseases. Further research is warranted to explore the therapeutic potential of enhancing CCT2-mediated aggrephagy in such diseases.
Insights
The chaperonin CCT2 acts as an autophagy receptor, selectively targeting aggregated proteins for degradation via aggrephagy. This discovery offers new insights into cellular protein quality control and potential therapeutic strategies for diseases linked to protein aggregation.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Protein aggregation is implicated in various human diseases.
- Autophagy, specifically aggrephagy, degrades protein aggregates.
- The selective mechanisms of aggrephagy are not fully understood.
Purpose of the Study:
- To investigate the role of CCT2 in regulating aggrephagy.
- To elucidate the mechanism of selective protein aggregate recognition by CCT2.
Main Methods:
- Mini-review of existing literature on CCT2 and aggrephagy.
- Analysis of CCT2's function as a molecular chaperone and autophagy receptor.
Main Results:
- CCT2, a subunit of the TRiC complex, functions as an autophagy receptor.
- CCT2 selectively targets solid protein aggregates for degradation via an ubiquitination-independent mechanism.
- CCT2 exhibits a functional switch from chaperone to autophagy receptor.
Conclusions:
- CCT2 plays a critical role in the selective degradation of protein aggregates.
- CCT2-mediated aggrephagy offers a novel pathway for cellular protein quality control.
- Targeting CCT2-mediated aggrephagy may hold therapeutic potential for neurodegenerative diseases.
More Related Videos
10:02Large-Scale Purification of Porcine or Bovine Photoreceptor Outer Segments for Phagocytosis Assays on Retinal Pigment Epithelial Cells
Published on: December 12, 2014
11:57Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
Published on: November 26, 2017
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Anaphase Promoting Complex
Protein Transport to the Thylakoids
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Protein Transport to the Outer Chloroplast Membrane
Two models describe the mechanism of precursor recognition and entry across the outer membrane through the TOC complex. Model 1 suggests the newly synthesized precursor binds to the TOC receptor 159 and forms a complex.
